RECRUITING

Patient Descriptors of Cancer-Related Fatigue: a Mixed Methods Pilot Study of Cancer Survivors

Talk to us

Conditions

CancerFatigue

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to better understand how cancer-related fatigue affects patients and how it's discussed with providers. This information will be used to develop an educational resource (visual aid poster) that could help individuals and their providers talk about cancer-related fatigue and which may help individuals better manage this symptom.

Official Title

Patient Descriptors of Cancer-Related Fatigue: a Mixed Methods Pilot Study of Cancer Survivors

Quick Facts

Study Start:2025-02
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06634381

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability to comply with study procedures for the duration of the study
  2. * Written informed consent and HIPAA authorization for release of personal information
  3. * Ability to read/write, understand and converse in English without the need for an interpreter
  4. * Men and women aged ≥ 18 years at the time of consent
  5. * White or Caucasian, Black or African American, or Hispanic or Latino/a
  6. * History of at least one survivorship care visit at the Department of Supportive Oncology at the Charlotte campus or at the Winston-Salem campus of AHWFBCCC
  7. * Completed curative treatment \> 6 months ago for any cancer type, with no detectable evidence of cancer
  8. * Self-reported fatigue score of ≥ 4 on the Numerical Rating Scale
  1. * Continuing maintenance therapy or other cancer-related treatment (i.e. immunotherapy or hormonal therapy)
  2. * History of or current severe or untreated depression
  3. * Hemoglobin \<11g/dL at last CBC SOC lab collection
  4. * History/diagnosis of dementia
  5. * Factors or conditions, for which participation may (1) not be in the best interest or (2) interfere with study assessment results (e.g. medical comorbidities, primary brain tumor/metastases)
  6. * No access to internet/Wi-Fi

Contacts and Locations

Study Contact

Alicia Patrick
CONTACT
(980) 292-1746
Alicia.Patrick@atriumhealth.org

Principal Investigator

Dori Beeler, PhD
PRINCIPAL_INVESTIGATOR
Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Study Locations (Sites)

Levine Cancer Institute
Charlotte, North Carolina, 28204
United States
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Dori Beeler, PhD, PRINCIPAL_INVESTIGATOR, Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02
Study Completion Date2025-06

Study Record Updates

Study Start Date2025-02
Study Completion Date2025-06

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer
  • Fatigue